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The	molecular	mechanisms	that	govern	bone	and	joint	formation	are	complex,	involving	an	integrated	network	
of	signaling	pathways	and	gene	regulators.	We	investigated	the	role	of	Hox	genes,	which	are	known	to	specify	
individual	segments	of	the	skeleton,	in	the	formation	of	autopod	limb	bones	(i.e.,	the	hands	and	feet)	using	the	
mouse	mutant	synpolydactyly	homolog	(spdh),	which	encodes	a	polyalanine	expansion	in	Hoxd13.	We	found	
that	no	cortical	bone	was	formed	in	the	autopod	in	spdh/spdh	mice;	instead,	these	bones	underwent	trabecular	
ossification	after	birth.	Spdh/spdh	metacarpals	acquired	an	ovoid	shape	and	developed	ectopic	joints,	indicating	
a	loss	of	long	bone	characteristics	and	thus	a	transformation	of	metacarpals	into	carpal	bones.	The	perichon-
drium	of	spdh/spdh	mice	showed	abnormal	morphology	and	decreased	expression	of	Runt-related	transcription	
factor	2	(Runx2),	which	was	identified	as	a	direct	Hoxd13	transcriptional	target.	Hoxd11–/–Hoxd12–/–Hoxd13–/–	tri-
ple-knockout	mice	and	Hoxd13–/–Hoxa13+/–	mice	exhibited	similar	but	less	severe	defects,	suggesting	that	these	
Hox	genes	have	similar	and	complementary	functions	and	that	the	spdh	allele	acts	as	a	dominant	negative.	This	
effect	was	shown	to	be	due	to	sequestration	of	other	polyalanine-containing	transcription	factors	by	the	mutant	
Hoxd13	in	the	cytoplasm,	leading	to	their	degradation.	These	data	indicate	that	Hox	genes	not	only	regulate	pat-
terning	but	also	directly	influence	bone	formation	and	the	ossification	pattern	of	bones,	in	part	via	Runx2.
Introduction
The molecular mechanisms that govern bone formation are com-
plex, but, based on genetic studies mainly in humans and mice, a 
network of important players that control individual steps of this 
process has emerged (1, 2). The early pattern step is determined by a 
number of signaling pathways, including the families of Homeobox 
(Hox), Sonic hedgehog (Shh), Fgf, and Wingless related (Wnt) genes. 
Thereafter, mesenchymal progenitor cells begin to adhere to each 
other and condense to form a template anlage of the future bone. 
In those bones that undergo endochondral ossification, chondro-
cytes in the middle of the anlage hypertrophy and mineralize; blood 
vessels invade, and the cartilage is removed and replaced by trabecu-
lar bone. At the same time, a bone shaft that will become the future 
cortical bone is formed surrounding the cartilaginous template. 
This part of the bone is derived from perichondrial cells that differ-
entiate directly into osteoblasts, a process that is initiated and con-
trolled by a series of transcription factors, of which Runt-related 
transcription factor 2 (Runx2) is probably the most important, as 
shown by gene inactivation experiments in mice (3).
The initial process of bone formation that takes place in the mid-
dle of the bone anlage is generally referred to as the primary ossifi-
cation center. Secondary ossification centers form in all long bones 
at later time points (usually after birth) in the cartilaginous ends of 
the bones. In these areas, separated from the primary ossification 
center through the growth plate, chondrocytes become hypertro-
phic, and their matrix mineralizes, is removed, and finally replaced 
by trabecular bone. The process is similar to that taking place in 
the primary ossification center, with the difference that no cortical 
bone is formed. Besides in the cartilaginous ends of long bones, 
trabecular ossification takes place in the carpal bones, which form 
the wrist in humans. The molecular processes that control primary 
versus secondary (trabecular) ossification are poorly understood.
Homeobox genes and the proteins they encode, the homeo-
domain proteins, play important roles in the developmental pro-
cesses of many multicellular organisms. A subgroup of these genes, 
the Hox genes, are found in clusters on the chromosomes. With-
in a cluster, the genes are arranged in the order of their function 
along the anteroposterior body axis (4). In mammals, 4 such clus-
ters exist, which harbor a total of 39 genes. During development 
of the limbs, Hox genes of the A and D clusters, and in particular 
those of the 5′ end, i.e., Hoxa10, -a11, -a13, Hoxd9, -d10, -d11, -d12, 
-d13, are of particular importance. The critical importance of Hox 
genes for normal growth and patterning of the autopod skeleton 
has been established via loss and gain of function manipulations in 
the mouse (5). Combinations of Hox proteins are thought to specify 
individual segments of the appendicular skeleton. In the hind limb, 
Hox10 paralogous genes are required to pattern the stylopod, 
and Hox11 paralogous genes are required to pattern the zeugo-
pod (6). Hox13 paralogous genes were shown to be important for 
patterning of the autopod (7). Overall, loss-of-function mutations in 
Hox genes appear to systematically involve loss or reduction of skeletal 
elements, and Hox gene function has accordingly been interpreted to 
specify individual segments of the limb in a proximo-distal fashion.
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Mutations in HOX genes result in human phenotypes. Expan-
sions of an alanine (Ala) repeat in HOXD13, for example, cause 
synpolydactyly, a limb malformation characterized by an addition-
al digit between digits 3 and 4 and a fusion (syndactyly) among 
these digits (8). The nature of this mutation has been studied 
in vitro and in a mouse mutant that carries the same mutation 
and hence was named synpolydactyly homolog (spdh) (9, 10). The 
polyalanine expansions in the human and mouse mutants result 
in intracellular aggregation and subsequent degradation of the 
mutant protein (11). This is likely to result in a dominant nega-
tive effect, as mice with inactivated Hoxd13 alleles do not show 
synpolydactyly (12, 13), but homozygous deficiency for Hoxd11, 
Hoxd12, and Hoxd13 is associated with central polydactyly similar 
to human synpolydactyly (14).
In this study, we focused on the process of bone formation in 
spdh mutant and Hox knockout mice. We show that spdh/spdh mice 
do not form cortical bone in the autopod. The perichondrium is 
insufficiently differentiated, and the absence of bone formation 
is accompanied by a loss of Runx2 expression. Runx2, in turn, is 
directly regulated by Hoxd13, indicating that Hox genes in the 
limb are upstream of Runx2. Although cortical bone is not formed, 
bone formation takes place after birth by secondary ossification 
of hypertrophic cartilage. Furthermore, the mutant metacarpals 
become more round in shape and form joint cartilage at their sides, 
thus mimicking the morphology of carpal bones. Our results show 
that Hox genes are important for bone formation in the limbs and 
determine the ossification pattern of bones.
Results
Abnormal ossification in spdh and Hox mutant mice. The synpolydactyly 
homolog mouse spdh carrying a homozygous expansion mutation 
with 7 additional alanines in the N-terminal polyalanine repeat of 
Hoxd13 showed a severely disturbed differentiation process of the 
distal skeletal elements. In newborn spdh/spdh mice, polydactyly and 
missing ossification centers were apparent (Figure 1A). In contrast 
to control mice, there was no proper separation of digital elements 
into metacarpals and phalanges, as no joints were formed. In areas 
in which Hoxd13 is not expressed, i.e., in the stylopod and zeugo-
pod, the skeleton was normal. At P4, Alizarin Red positive zones 
appeared, with an irregular shape and distribution corresponding 
to mineralized hypertrophic chondrocytes. These areas became 
broader at P7 and expanded over the entire distal forelimb. By P14, 
the entire autopod skeleton was mineralized. We investigated the 
metacarpal bones in more detail to analyze the process of mineral-
ization and ossification (Figure 1B). Control mice at P0 showed 
cortical bone in the middle and trabecular bone at the ends, near 
the growth plates. By P7, this zone had expanded and additional 
zones of mineralization that would become the later secondary 
ossification centers appeared at the distal end. In spdh/spdh mice, 
no mineralization was present at P0. At P7, mineralized cartilage 
was observed, but no cortical bone. At P14, most of the mineralized 
cartilage had been removed and replaced by trabecular bone.
In previous reports, it was shown that a triple inactivation of 
Hoxd11, Hoxd12, and Hoxd13 results in a synpolydactyly pheno-
type (14). We investigated mineralization and ossification in 
these mice. As shown in Figure 1, A and B, Hoxd11,12,13del/del mice 
exhibit defect similar to that of spdh/spdh mice. There was no 
mineralization at P0. At P7, most metacarpals were mineralized, 
but the majority of mineral was present within the chondrocytes. 
The overall phenotype, however, was milder than in spdh/spdh 
mice. We observed that centers of mineralization appeared ear-
lier (at P2) in the Hoxd11,12,13del/del mice than in spdh/spdh mice.
To compare the effect of the mutation with the effect of lack of 
single Hox genes, we investigated mice with other inactivated Hox 
genes (Figure 1C). Inactivation of Hoxd13 results in a relatively mild 
phenotype consisting of an overall reduction in size and abnormal 
metacarpophalangeal joints, but pentadactyly (13). In digit 2, how-
ever, abnormal ossification was present in the proximal part of the 
metacarpal. Here, a pattern similar to that observed in the spdh/spdh 
mice was observed, resulting in a bone that, at least partially, consisted 
of trabecular bone only. Hoxa13 is largely coexpressed with Hoxd13 in 
the distal limb. We therefore investigated possible genetic interactions 
among the spdh allele, Hoxd13, and Hoxa13. Mice with inactivated 
Hoxd13 and 1 inactivated Hoxa13 allele (Hoxd13–/–; Hoxa13+/–) showed 
a severe phenotype with very small autopods consisting of 6 digits 
without joints as previously reported (7, 15). Similar to the spdh/spdh 
mutants, these mice showed a complete lack of mineralization at P0. 
At P7, mineralization was present, but only within the cartilage anla-
gen. No cortical bone was identified. Spdh/spdh mice with 1 inactivated 
Hoxa13 allele (spdh/spdh; Hoxa13+/–) showed the most severe pheno-
type. We observed a fusion of all cartilaginous elements that were 
greatly reduced in size. Mineralization was highly abnormal, showing 
only mineralized cartilage and no cortical bone formation.
Abnormal perichondrium in spdh mutant mice. Based on our previ-
ous finding that spdh/spdh mice show narrow interdigital spaces 
with partially fused cartilaginous rudimentary fingers and no clear 
border formation, we characterized the perichondrial layer in more 
detail. WT mice showed a broad peridigital expression of Hoxd13 
protein with enhancement in the perichondrial layer. In spdh/spdh 
mice, Hoxd13 protein was reduced and showed an abnormal distri-
bution (Figure 2A). Histological analysis of the perichondrium in 
WT mice showed the typical elongated fibroblast-like cells around 
the cartilage anlagen that form the perichondrium and, at a later 
stage, the periosteum. These cells were apparently absent in spdh/spdh 
mice. Periostin, a gene predominantly expressed in the periosteum 
and perichondrium, and collagen type 2 alpha 1 (Col2a1) showed 
a mutually exclusive expression pattern in WT mice. In spdh mice, 
the expression patterns were overlapping, resulting in fuzzy contours 
(Supplemental Figure 1; supplemental material available online with 
this article; doi:10.1172/JCI41554DS1). Furthermore, chondrocytes 
as well as perichondrial cells had lost their polarity (Figure 2B).
Perichondrial cells express a number of genes that correspond 
to the different layers of cell differentiation within this tissue. 
Collagen type 1 alpha 1 (Col1a1) was strongly upregulated in peri-
chondrial cells in WT (Figure 2, C and D). In spdh/spdh mice, we 
observed low Col1a1 expression in the interdigital space and very 
little expression in the cells adjacent to the chondrocytes. The same 
was shown for collagen type 1 protein. Other genes known to be 
expressed in the perichondrium were also downregulated. These 
included periostin (Postn) (16), Wnt5a (17), cellular retinoic acid 
binding protein 1 (Crabp1), and tumor suppressor region 2 protein 
(Tsp2) (18), as shown by in situ hybridization (Figure 2E).
To determine whether these genes are regulated by Hoxd13, we 
infected chicken micromass cells (chMM) plated at high density 
with a RCASBP retrovirus (replication-competent ASLV [avian 
sarcoma-leukosis virus] long terminal repeat [LTR] with a splice 
acceptor and Bryan polymerase) expressing WT and mutant 
Hoxd13. mRNA levels were quantified and compared with control 
levels (empty virus). As shown in Figure 2F, Hoxd13 WT expres-
sion upregulated the perichondrially expressed genes Tsp2, Postn, 
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and Wnt5a and, in a moderate manner, the genes Col1a1 and 
Crabp1. Mutant Hoxd13 with an alanine expansion (+7 Ala and 
+14 Ala), in contrast, resulted in no significant increase or even in 
a suppression. Protein expression of WT and mutant Hoxd13 was 
verified on Western blot with anti-FLAG or anti-Hoxd13 anti-
bodies. Other markers that are expressed by preosteoblasts, such 
as osteopontin, were not detectable in spdh/spdh mice, indicating 
the absence of osteoblasts and their precursors (not shown).
Hox genes regulate Runx2. Runx2 is a transcription factor that 
is essential for bone formation (3). We therefore investigated 
Figure 1
Skeletal phenotype of Hox mutant mice. (A) Skeletal preparations of postnatal stages P0, P4, P7, and P14 of WT, spdh/spdh, and Hoxd11,12,13del/del 
(Δd11-d13) mice. Cartilage stained with Alcian Blue, bone with Alizarin Red. Note additional digit-like structures, a severe delay in ossification, and 
missing joints in mutant mice. (B) Histology (von Kossa) of postnatal stages P0, P7, and P14 of WT, spdh/spdh, and Hoxd11,12,13del/del (Δd11-d13) 
metacarpals. Mineralized regions are black, counterstaining with Toluidine Blue and Picro Fuchsin Red. At P0, WT mice show both cortical (C) and 
trabecular bone (tb) and adjacent growth plates (gp). In mutant mice, mineralization and hypertrophic chondrocytes are completely missing. At P7 
in WT, secondary ossification centers are visible at the distal ends of metacarpals. In mutant mice, hypertrophic chondrocytes and mineralized car-
tilage are present but no cortical bone. At P14 in WT, mineralized cartilage of secondary ossification centers has been replaced by trabecular bone; 
cortical bone has expanded. In spdh/spdh and Hoxd11,12,13del/del (Δd11–d13) mutants, growth plates are disorganized; mineralized regions have 
partly been replaced by trabecular bone. No cortical bone is present. Original magnification, ×200. (C) Skeletal preparations at P0 and P7, histology 
of metacarpals at P7 of Hoxd13–/–, Hoxd13–/–; Hoxa13+/–, and spdh/spdh; Hoxa13+/– mutant mice. Hoxd13–/– mutants exhibit a delay in ossification. 
Hoxd13–/–; Hoxa13+/– mice show a severe ossification defect at P0 and abnormal bone formation at P7 similar to the spdh/spdh mice. Spdh/spdh; 
Hoxa13+/– mutant mice show a similar but more severe phenotype.
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the expression of Runx2 in the metacarpals of spdh/spdh mice. As 
shown in Figure 3A, Runx2 was expressed in the perichondrium/
periosteum of E13.5 metacarpals and phalanges but not the car-
pals of WT autopods. In contrast, spdh/spdh mice showed strongly 
reduced levels of Runx2 expression. This reduction was most pro-
nounced in the metacarpal region and corresponded well with 
the complete lack of cortical bone in this region. To determine 
whether the trabecular bone formation observed at later post-
natal stages escapes this apparent lack of Runx2 expression, we 
performed in situ hybridization of Runx2 on P7 limbs (Supple-
mental Figure 2). We observed Runx2 expression in hypertrophic 
chondrocytes and osteoblasts, indicating that Runx2 is initiated 
with the onset of hypertrophy but is extremely delayed.
Two color in situ hybridizations at stages E13.5 (Figure 3B) 
demonstrated coexpression of Hoxd13 and Runx2 in perichondrial 
cells. We therefore tested to determine whether Hoxd13 and other 
Figure 2
Abnormal perichondrium in spdh/spdh mice. (A) Immunohistochemistry of WT and spdh forelimbs at E13.5. Hoxd13 protein (green) shows 
abnormal distribution and reduced amount in spdh/spdh mice. Lower panel shows magnification without DAPI merge. Original magnification, ×200 
(lower panels). (B) Morphology of perichondrial regions at E14.5 in WT and spdh/spdh mice (Nomarski interference contrast). Chondrocytes of 
spdh/spdh mice show no apparent orientation, and the flattened perichondrial cells are missing. (C) Immunolocalization and (D) in situ hybridiza-
tion of Col1a1 on sections of WT and spdh/spdh metacarpals at E13.5. Col1 protein as well as mRNA is greatly reduced in mutants. Magnifications 
shown in the lower panel. (E) In situ hybridizations of perichondrially expressed genes Wnt5a, Crabp1, and Tsp2 at E14.5 in WT and spdh/spdh 
metacarpals. Note strong downregulation in spdh/spdh animals. Panels show a higher magnification of the perichondrium. Original magnification, 
×400 (panels); ×1000 (insets). (F) Expression of WT but not mutant Hoxd13 in chMM results in the upregulation of perichondrially expressed genes 
Col1a1, Wnt5a, Postn, Crabp1, and Tsp2. Fold change values are referred to control for each gene. Data represent mean ± SD.
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autopod-expressed Hox genes are capable of inducing Runx2 in 
mesenchymal progenitor cells. We infected chMM with a RCASBP 
retrovirus containing WT or mutant Hoxd13 and quantified mRNA 
levels by quantitative PCR (qPCR). As shown in Figure 3C, Hoxd13 
expression by RCASBP in chMM resulted in an upregulation of 
Runx2 mRNA. The expression of the +14 Ala Hoxd13 mutant result-
ed in a suppression of Runx2 compared with control infected cells.
To determine whether Runx2 is directly regulated by Hox genes, 
we performed promoter luciferase assays using a 0.543-kb fragment 
of Runx2 exon 1 promoter (19) (Figure 3D). We found that Hoxd13 
strongly activated the promoter, whereas the +7 Ala mutant result-
ed in less activation and the +14 Ala mutant showed no significant 
induction. In addition, Hoxa13, and to a lesser degree Hoxd11 and 
Hoxd12, showed induction of the Runx2 promoter. To determine 
whether Hoxd13 is able to directly bind to the Runx2 exon 1 pro-
moter, we performed ChIP on chMM cells infected with a Hoxd13-
expressing retrovirus (Figure 3E). After immunoprecipitation, bind-
ing of Hoxd13 to the Runx2 promoter was determined by qPCR 
using primer pairs P1 to P4. We detected a significant enrichment 
for regions of the Runx2 promoter that are flanked by primer pairs 
P2 and P3, with close position to the assumed transcriptional start 
site, and to a lesser extent for the amplicon of P1, but not for the 
control (P4). The Hoxd13-binding matrix from Berger et al. (20) 
was used to identify potential Hoxd13-binding sites within the frag-
ment of the mouse distal Runx2 promoter. Five potential binding 
sites were found, at positions –380, –90, –78, –63, and +47 relative to 
the transcription start site. Deletion of binding sites 2–4 decreased 
induction of the Runx2 promoter by Hoxd13 to approximately 60% 
of the WT promoter (Figure 3D). Mutations of single binding sites 
1, 3, 4, or 5 had no significant effect on Hoxd13-mediated activa-
tion of the Runx2 promoter, whereas mutation of binding site 2 
at position –90 reduced promoter activity by approximately 25%. 
Binding sites 2–4 lie within a conserved region and can be found 
in the chicken Runx2 promoter as well. This region is enriched in 
ChIP using chMM. EMSAs showed binding of Hoxd13 to oligos 
containing binding sites 2–4 and 5 (data not shown).
Figure 3
Hox genes regulate Runx2. (A) In situ hybridization with specific probe against Runx2 on WT and spdh/spdh limbs at E13.5, E14.5, and E16.5. 
Note strongly reduced expression in mutant mice. (B) Double fluorescent in situ hybridization for Hoxd13 (red) and Runx2 (green) on E13.5 
WT limbs. Hoxd13 expression overlaps with Runx2 in the perichondrium. (C) qPCR analysis of chMM. Expression of WT Hoxd13, but not of 
mutant Hoxd13 (+7 and +14Ala) in chMM results in upregulation of Runx2. Fold changes refer to control at day 2. (D) Luciferase promoter assay 
shows activation of P1 promoter of Runx2 by WT but not by mutant Hoxd13. Activation is achieved in a lesser degree by Hoxd11, Hoxd12, and 
Hoxa13. Mutation of a putative Hoxd13-binding site at position –90 (mut[2]) and deletion of putative binding sites at –90, –78, and –63 (del[2–4]) 
decreases the Hoxd13 effect. Fold induction reflects the ratio of activation by gene of interest versus activation by empty vector in respective 
promoter constructs. (E) ChIP of Runx2 promoter P1 in chMM expressing Hoxd13. Enrichment with primer pairs P1, P2, and P3 but not P4. Posi-
tion of primers is given in the schematic to the right. (F) Hoxd13 and Hoxa13 regulate Bmp4 in chMM. Fold changes refer to control at day 12. 
(G) Expression of Bmp4 in WT and spdh/spdh metacarpals at E14.5. Data in C, D, E, and F represent mean ± SD.
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Runx2-dependent bone formation requires bone morphogenetic 
protein (Bmp) signaling (21). As the Bmp4 promoter was shown to be 
activated by Hoxd13 and Hoxa13 (22), we investigated which of the 
5' Hox genes are able to upregulate Bmp4 expression in chMM. Bmp4 
was induced by Hoxd13 and Hoxa13 (Figure 3F), but not by Hoxd11 
and Hoxd12. Interestingly, Runx2 also had an upregulating effect on 
Bmp4 expression, suggesting that Runx2 and Bmp4 are coupled in a 
regulatory circuit. In the WT E14.5 autopod, Bmp4 is expressed in 
the perichondrium. In spdh/spdh mice, Bmp4 was strongly diminished 
and restricted to the distal parts of the digit anlagen (Figure 3G).
Homeotic transformations of metacarpal to carpal bones. Figure 4A 
shows the ossification process in WT carpals, the secondary ossifi-
cation centers of WT metacarpals, and spdh/spdh carpals and meta-
carpals. Cortical bone was present in the WT metacarpal bone shaft 
only. There was no difference between the ossification patterns of 
WT and spdh/spdh carpals. In contrast, spdh/spdh metacarpals showed 
a pattern similar to that of WT carpals and the secondary ossifica-
tion center of the metacarpals. Furthermore, the overall shapes of 
spdh/spdh metacarpals were more carpal-like. Thus, the ossification 
of spdh/spdh metacarpals appeared to follow a secondary ossification 
Figure 4
Homeotic transformation in Hox 
mutant mice. (A) Histology at P7 
of WT and spdh/spdh forelimbs. 
Mutant metacarpal bones show 
mineralized cartilage (black) 
similar to WT carpal bones or 
secondary ossification cen-
ters. Mutant metacarpals have 
adopted a round carpal-like 
shape with joint-like gaps. c, car-
pal; cb, cortical bone; so, sec-
ondary ossification center. (B) 
Higher magnification (×200) of 
metacarpal bones. WT cortical 
bone of metacarpals (black) is 
separated by connective tissue 
(pink). In mutant mice, carpal 
bones are surrounded by carti-
lage. This cartilage has a similar 
morphology to that in the joints 
of WT carpal bones. (C) In situ 
hybridization against Col2a1. 
At E14.5, Col2a1 is expressed 
throughout the cartilaginous 
anlage. At P7, WT (compos-
ited view) Col2a1 is expressed 
around the carpal bones and 
secondary ossification centers 
marking the joint cartilage. In 
spdh/spdh forelimbs, Col2a1 
is expressed in a narrow band 
around the metacarpals similar 
to that seen in WT carpals. (D) 
X-rays of a patient with synpoly-
dactyly. Carpals (c) have a round 
shape; metacarpals (m) are long 
bones, with cortical bones in 
the shaft region. In the patient, 
metacarpal bones have adopted 
a carpal-like shape. (E) In situ 
hybridization of Gdf5 at E12.5 
to E16.5. In spdh/spdh limbs, 
Gdf5 is expressed around the 
cartilage anlagen. Boxes show 
magnifications (×250). (F) In situ 
hybridizations at E14.5 with joint 
markers Sfrp2, Wnt4, and Dkk3. 
In all cases, joint expression 
is lost in spdh/spdh animals; 
instead, there is an upregulation 
in perichondrial regions along 
the metacarpal structures.
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scheme both in time and morphology (Supplemental Figure 3). In 
WT long bones, perichondrial cells are oriented in parallel layers 
around the cartilage anlage. The cells that surround carpal bones 
lack this polarity at early stages. This is similar to the spdh meta-
carpal region. Later, at E16.5, the WT carpal cells adjacent to the 
joint space became flattened, but they showed tangential instead of 
perpendicular orientation in comparison with the axis of the inner 
cells. This difference in lineage determination was accompanied 
by differences in the expression of Runx2, Bmp4, and osteopontin, 
which are highly expressed in the perichondrium of metacarpals 
and phalanges but not in the carpals (Supplemental Figure 4).
Histological examination showed minimal amounts of tissue 
between the spdh/spdh metacarpals. In contrast, the area between 2 
WT metacarpals was filled with periosteum and connective tissue. 
In spdh/spdh mice, the mineralized hypertrophic cartilage was covered 
by cartilage that resembled the joint surface of carpals (Figure 4B). 
Expression analysis of Col2a1, the cartilage-restricted collagen, showed 
expression throughout the cartilaginous anlagen in WT and mutant 
digits at E14.5 (Figure 4C). At P7, Col2a1 expression was restricted in 
WT mice to the growth plates and the joints of the carpal and meta-
carpal bones. In spdh/spdh mice, Col2a1 expression was present around 
the metacarpal bones, giving them a carpal-like appearance.
To determine whether early markers of joint development were 
expressed in these ectopic joints, we performed in situ hybridization 
with probes for growth and differentiation factor 5 (Gdf5), secreted 
frizzled-related protein 2 (Sfrp2), Wnt4, and dickkopf homolog 3 
(Dkk3). In spdh/spdh mice, the initial pattern of Gdf5 expression at 
E12.5 was similar to that of WT mice, but it did not change with 
time, i.e., it remained around the cartilage anlagen. Even at late 
stages (E16.5), we detected Gdf5 expression between the metacar-
pals (Figure 4E). Similar results were obtained for Sfrp2, Wnt4, and 
Dkk3, indicating that joint cartilage was specified at the wrong loca-
tions, i.e., not at the ends of the bones, but at their sides (Figure 4F). 
Besides being detected in the metacarpo-phalangeal joints, Dkk3 
was found strongly expressed around the carpals and downregu-
lated in the perichondrium. In spdh/spdh mice, this pattern was lost 
and expression was observed not only around the carpals but also 
surrounding the metacarpals, indicating a lack of downregulation 
in the perichondrium. These results indicate that spdh/spdh meta-
carpals had adopted a fate similar to that of carpal bones.
An x-ray of a normal human hand (Figure 4D) illustrates the char-
acteristic ossification pattern of metacarpals, with thick cortical 
bone, a bone marrow cavity, and trabecular bone with adjacent joints 
at the ends. In contrast, the carpal bones, located between the meta-
carpals and radius/ulna, are round in shape and have a trabecular 
ossification pattern. The x-ray of an individual with a homozygous 
HOXD13 +9 Ala mutation (Figure 4D) shows metacarpal bones lack-
ing their typical longitudinal pattern. Instead, they have a round shape 
and an ossification pattern that is similar to that of carpal bones.
Molecular pathology of the spdh mutation. Spdh/spdh mice have a dif-
ferent and more severe phenotype than Hoxd13-knockout mice, 
indicating that the spdh allele is not a loss of function but rather 
exerts a neomorphic and/or antimorphic effect. To test the possibil-
ity that mutant Hoxd13 might interact with and partially inactivate 
Hoxa13, we performed in vitro overexpression experiments with 
WT and mutant Hoxd13 together with Hoxa13. Mutant Hoxd13 
forms intracellular aggregates that prevent the protein from enter-
ing the nucleus (11). Coexpression of mutant (+14 Ala) Hoxd13 with 
WT Hoxa13 resulted in the sequestering of Hoxa13 in the Hoxd13 
aggregates (Figure 5A). The same effect was observed with other 
polyalanine-containing transcription factors such as Runx2 (Fig-
ure 5A). To investigate the specificity of the interaction of mutant 
Hoxd13 with WT Hoxa13, we performed a series of coexpression 
experiments. Coexpression of mutant Hoxd13 with WT Hoxd12 
did not change its nuclear localization (Figure 5B). Coexpression 
of mutant Hoxd13 with WT Hoxd13, however, resulted in accumu-
lation of WT protein in the aggregates. To determine whether the 
observed effect was due to the polyalanine tract, which is present in 
Hoxd13 and Hoxa13, but not in Hoxd12, we constructed a mutant 
version of Hoxd13 with only 2 alanines (2 Ala), replacing the WT 15 
alanine stretch. In contrast to the WT, this version of Hoxd13 (2 Ala) 
was found in the nuclei only, indicating that the polyalanine stretch 
was essential for the observed cytoplasmic sequestering effect.
We next tested to determine whether other transcription factors 
with polyalanine expansions as they occur in hand-foot-genital 
syndrome (HOXA13) (23) and cleidocranial dysplasia (RUNX2) 
(24) behave in a similar way (Figure 5C). Coexpression of mutant 
HOXA13 (+10 Ala) together with WT Hoxd13 resulted in the for-
mation of aggregates that contained both proteins. Coexpression 
of mutant RUNX2 (+10 Ala) with WT Hoxd13 had the same effect, 
indicating that expanded alanine repeats have a general tendency 
to interact with other polyalanine-containing proteins, resulting 
in their sequestration in cytoplasmic aggregates.
To investigate the level of Hoxa13 in vivo, we performed 
immunohistochemistry with a Hoxa13-specific antibody (Figure 
5D). We obtained nuclear staining in the autopod, but not in other 
regions of the limb. In WT mice, staining was found mainly in 
interdigital spaces and the perichondrium and localized to the 
nucleus. In the spdh/spdh mutant, staining intensity was reduced 
and diffuse. Higher magnification showed that Hoxa13 protein 
was mainly present in the cytoplasm with less staining in the 
nuclei. These results indicate a reduced level of active Hoxa13 pro-
tein in spdh/spdh limbs. Misfolding and aggregation of proteins is 
frequently associated with degradation and has also been observed 
for Hoxd13 in spdh/spdh limbs (11) We therefore tested the amount 
of Hoxa13 protein in spdh/spdh limbs at E13.5 via Western blot. 
As illustrated in Figure 5E, spdh/spdh limbs showed a reduction of 
Hoxa13 protein when compared with WT limbs.
Discussion
One important aspect of limb development is the establishment 
of a system of signaling molecules that determine the anteroposte-
rior, proximodistal, and dorsoventral axes of the limb. This system 
ultimately controls the formation of skeletal precursor elements, 
which are laid down in a proximodistal fashion. A continuous 
challenge in the field of limb development research has been the 
question of where Hox genes fit into the molecular-genetic pro-
gram of patterning and organogenesis of such elements. HoxA and 
HoxD genes belonging to the same paralogous group show simi-
lar expression patterns (5). During an early phase, Hox genes are 
involved in the regulation of anterior-posterior polarity through 
the control of Shh expression, the mediator of polarity in the limb 
(25). This regulation is likely controlled by the binding of Hox 
genes to a limb regulatory region upstream of the Shh gene (26). 
The function of Hox genes at a later phase of limb development is 
less well defined but is likely to involve the regulation of cell differ-
entiation. Recently, we were able to show that Hox genes suppress 
chondrogenesis directly and indirectly by regulating retinoic acid 
concentration in the limb bud (27). These studies indicate that 
Hox genes not only have a role in early patterning processes but are 
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Figure 5
The dominant negative nature of polyalanine expansions. (A) WT Hoxd13 and WT Hoxa13 colocalize in the nucleus; expression of mutant 
Hoxd13 (+14 Ala) results in cytoplasmic aggregates. Coexpression of mutant Hoxd13 with WT Hoxa13 results in localization of Hoxa13 
in aggregates. The same is true when coexpressing mutant Hoxd13 with Runx2 (lower panels). (B) Coexpression of Hoxd13 mutant with 
Hoxd13 WT, but not with Hoxd12 WT, results in sequestration of the WT protein in aggregates. Coexpression of mutant Hoxd13 with 
Hoxd13 with reduced alanine stretch (2 Ala) results in localization of the 2 Ala Hoxd13 in the nucleus. (C) Mutant Hoxa13 (+10 Ala) as well 
as mutant Runx2 (+10 Ala) form aggregates in cytoplasm. Coexpression with WT Hoxd13 results in localization of Hoxd13 in aggregates. 
(D) Immunohistochemistry of WT and spdh/spdh limbs at E14.5. Hoxa13 protein (green) is localized in nuclei of perichondrial cells. In 
spdh/spdh mice Hoxa13 protein shows an abnormal distribution with reduced intensity and cytoplasmic localization. Boxes mark magnifications 
(×630) of the perichondrial regions of metacarpals. Original magnification, ×630 (A–C); ×200 (D). (E) Western blots on limb lysates of WT and 
spdh/spdh limbs at E13.5 showing a reduction of Hoxa13 as well as Hoxd13 protein.
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also important for cell differentiation. The data presented in this 
study indicate that Hox genes have an instructive role in determin-
ing the shape and ossification patterns of bones in the limbs.
The formation of all long bones starts with a cartilaginous model 
(anlage) of the future bone, which is subsequently replaced by bone. 
The formation of joints is an important step in this process, as it 
results in the persistence of cartilage in the articulating region in con-
trast to the rest of the bone. The signaling molecule Gdf5 has been 
linked to joint development, and lineage experiments have shown 
that joint cells originate from Gdf5-positive precursors (28). During 
early development (E12.0 in the mouse), Gdf5 expression is found in 
the interdigital mesenchyme surrounding the cartilaginous anlagen. 
Shortly thereafter, Gdf5 expression moves toward the future joints 
and is now found in a band of cells oriented perpendicular to the 
cartilage anlagen. In spdh/spdh mice, this shift of Gdf5 expression does 
not take place. Instead, Gdf5 and other joint-expressed genes, such as 
Sfrp2, Wnt4, and Dkk3, continue to be expressed around the cartilage 
anlagen similar to the situation in the case of carpal bone anlagen.
After the initial process of mesenchymal condensation and chondro-
genesis, which results in the formation of the cartilage anlagen, a spe-
cialized tissue is formed, the perichondrium. Whereas chondrocytes are 
oriented perpendicular to the long axis of the skeletal elements, peri-
chondrial cells are parallel to this axis. Interdigital mesenchymal cells 
have, in contrast, no apparent orientation. We investigated spdh/spdh 
mutants and show that neither the orientation of cells nor the expect-
ed change in gene expression takes place. Instead, spdh/spdh cells adja-
cent to the cartilage anlage stay in a nonoriented undifferentiated 
stage. Matrix molecules such as collagen type 1, Crabp1, and Tsp2 as 
well as signaling molecules such as Wnt5a are expressed at very low 
levels, indicating that the cells fail to develop into perichondrial cells. 
On the other hand, genes such as Dkk3 that are expressed in the joints 
and that are consequently downregulated in the perichondrium are 
expressed at high levels around the metacarpal anlagen in spdh/spdh 
mice. We hypothesize that this absence of a functioning perichon-
drium influences the chondrocytes in the cartilage anlage. Indeed, 
these cells have been shown to have low proliferation rates, do not 
hypertrophy, and do not become fully differentiated (9).
Cortical bone is generated by perichondrial precursor cells that 
differentiate into osteoblasts. Runx2 has been shown to be essential 
for this step, as Runx2-knockout mice do not form bone at all (3). We 
show here that Hoxd13 is a positive regulator of Runx2 expression. A 
regulation of Runx2 by homeobox genes has been postulated before. 
Muscle segment homeobox gene 2 (Msx2), distal-less homeobox 
gene 5 (Dlx5), Dlx3, and Hoxa10 were shown to regulate the activity 
of Runx2, indicating that a network of homeobox genes is involved 
in the control of Runx2 expression (19, 29, 30). Our results support 
this hypothesis and show that Hox deficiency results in deficient 
bone formation not only in vitro but also in vivo. The effect of Hox 
on Runx2 is likely to be enhanced by the regulation of Bmps, in par-
ticular Bmp4, by Hox genes. Hoxd13 mutants with elongated poly-
alanine repeats lose their ability to activate the Bmp4 promoter (data 
not shown), and spdh/spdh mutant mice show a diminished expres-
sion of Bmp4. Reduced levels of Bmps will, in turn, result in a further 
reduction of Runx2 and also Osterix expression, as both transcrip-
tion factors are downstream targets of the Bmp pathway (29).
Homeosis, the transformation of one body part into another, 
is associated with mutations in or misexpression of Hox genes. In 
Drosophila, examples of such mutations are antennapedia and the 
bithorax series of mutations. Homeotic transformations have also 
been observed in mice. Here, inactivation of certain Hox genes or 
all paralogous groups results in a change in the identity of one or 
many vertebrae into the identity of others (6, 15, 31). Unlike the sit-
uation in the trunk, loss-of-function phenotypes in the limbs have 
not been interpreted as classical homeotic transformations (5). We 
propose that the inactivation of Hox genes in the autopod affects 
growth and differentiation of cartilaginous elements in such a way 
that the result is homeotic transformation of metacarpal bones.
The results of our study show that metacarpals lose their identity as 
long bones and are transformed into carpal-like bones. This transfor-
mation is accompanied by a change in the 3 major attributes of long 
bones, i.e., the presence of cortical bone, the position of the joints, 
and the shape of the bone. In long bones, the joints are positioned at 
the ends, the cortical bone is at the midshaft region, and the shape is 
that of a cylinder with cartilaginous ends. In round bones, such as the 
carpals, there is no cortical bone, joints surround the bone, and the 
shape is that of an ovoid disc. The absence of cortical bone in carpals 
also determines their pattern of ossification. In contrast to long bones 
that form primary ossification centers, carpal bones ossify through a 
process similar to secondary ossification. In addition, primary ossi-
fication of long bone cartilage models takes place during develop-
ment (in the mouse E13.5), whereas secondary ossification happens 
at defined time points after birth. Here we show that the pattern of 
ossification and the time of ossification of mutant metacarpals are 
similar if not identical to those of the secondary ossification centers 
of WT carpals and long bones. Thus, the spdh metacarpals fulfill all 
criteria of ovoid, carpal bones, arguing that a transformation of one 
body part into another and thus a homeotic transformation has taken 
place. The observed change in identity cannot be explained by the 
lack of bone formation or the defect in chondrocyte differentiation. 
Inactivation of Ihh, for example, results in a complete absence of bone 
and severely disturbed chondrocyte differentiation. In spite of this, 
the long bones of Ihh–/– mice do not become round; neither are they 
surrounded by joints. They retain their original shape, while being 
shorter (32). The same holds true for Runx2–/– mice, in which, despite 
a complete absence of bone, the cartilage anlagen do not change their 
overall shapes, each element being easily recognizable (3). This is most 
likely due to the relatively late effect of Runx2, which exerts its major 
role in the specification of osteoblasts and the regulation of differen-
tiation of precursor cells into this lineage. Hox genes, in contrast, act 
much earlier and are able to regulate other genes in this pathway such 
as the BMPs. As we had previously reported (9), BMPs are regulated by 
Hoxd13 before Runx2 starts to be expressed. This indicates that Hox 
genes organize and dictate the emergence of the perichondrium and 
that Runx2 is a downstream player.
We observed a similar effect in Hoxd11,12,13del/del, as well as in 
Hoxd13–/–; Hoxa13+/– mice, as the metacarpals of these mutants 
also do not have cortical bone and ossify according to the second-
ary ossification scheme. Thus, Hox genes of the 5′ D and A cluster 
determine the shape and identity of autopod metacarpal skeletal 
elements. Patients that are homozygous for polyalanine expansion 
mutations have a severe limb phenotype consisting of polydactyly 
and severe brachydactyly (8, 33). In these individuals, the meta-
carpals also lose their identity of long bones and become round, 
carpal-like bones. On x-ray this transformation is evident, as these 
bones do not show the clear distinction between cortical and tra-
becular bone as observed in WT metacarpals. Furthermore, sur-
gical reports indicate that these bones are covered with cartilage, 
thus giving them a joint-like appearance (34).
Polyalanine repeats are relatively common in transcription fac-
tors, but their functional role remains unclear. The length of the 
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glutamine/alanine repeat in Runx2 was shown to affect transcrip-
tional activity and was proposed to be involved in the evolution of 
facial length in carnivores (35, 36). In Hoxd13, a novel expansion of 
the polyalanine tract was identified in cetaceans (whales, dolphins) 
compared with other mammals, indicating a role in the morpholog-
ical diversity of the cetacean autopod (37). Polyalanine mutations 
can be classified as a separate class of repeat expansions associated 
with developmental malformations. With one exception, all poly-
alanine repeat mutations have been reported in transcription fac-
tors (38). For most polyalanine mutations, loss of function due to 
protein degradation seems to be the major pathogenic mechanism 
(11). In Hoxd13, however, the size of the polyalanine expansion cor-
relates with the severity of the disease (39), and recent studies have 
shown that expansion of polyalanine repeats in Hoxd13 results in 
a combination of loss of function and gain of function (27). The 
latter involves a negative effect on other Hox genes (10).
In this study, we have addressed the molecular basis of this obser-
vation. Based on the finding that Hoxd13–/–; Hoxa13+/– mice show 
changes similar to those of the spdh/spdh mutant mice, we tested the 
hypothesis that mutant Hoxd13 might interact with WT Hoxa13. 
Based on colocalization of Hoxa13 with Hoxd13+14ala in cytoplasmic 
aggregates, abnormal distribution of Hoxa13 protein in spdh/spdh 
limbs, and a downregulation of Hoxa13 protein in spdh/spdh limbs, 
we propose that mutant Hoxd13 associates with WT Hoxa13, 
which results in a degradation not only of the mutant Hoxd13 but 
also of WT Hoxa13. Furthermore, we show that this interaction is 
likely to be mediated via the polyalanine stretch. This explains why 
other Hoxd genes, such as Hoxd12, which lack a polyalanine stretch 
do not colocalize with the mutant Hoxd13 protein (11).
In addition, our findings suggest that mutant Hoxd13 is able to 
interact with other proteins that carry polyalanine repeats, such 
as Runx2. This is likely to increase the negative effect of mutant 
Hoxd13 on Runx2. Furthermore, the observation that transcrip-
tion factors with expanded alanine repeats bind to other poly-
alanine–containing proteins offers a new understanding of the 
pathogenesis of polyalanine repeat–related diseases. It may also 
explain clinical features that are not considered part of the classi-
cal phenotype. For example, in a family with a polyalanine expan-
sion in RUNX2, brachydactyly was observed in addition to cleido-
cranial dysplasia, the known phenotype associated with RUNX2 
haploinsufficiency (24). Brachydactyly has also been observed as a 
consequence of mutations in HOXD13, indicating a double effect 
(loss of HOXD13 and RUNX2 function) in affected individuals.
Methods
Patients. The patient with synpolydactyly is from Pakistan. X-ray examination 
was performed for diagnostic reasons. DNA was extracted with standard 
methods from peripheral blood. Sequencing of HOXD13 was performed as 
described previously (8). The patient gave written informed consent.
Mice. Spdh/+ mice were obtained from Jackson Laboratory (40). Mutant 
offspring were generated by breeding spdh/+ females to spdh/+ males. 
Mutant mice with conditional knockout of Hoxd11,12,13del/del in the limbs 
were generated by crossing mice carrying flox (flanked by loxP sites) alleles 
of Hoxd11,12,13 with transgenic mice expressing cyclization recombinase 
under the control of periaxin 1 promoter (Prx1-Cre). On the day of vaginal 
plug, embryonic stage at 12 pm was considered to be E0.5. Genotyping was 
performed as described previously (27), using DNA from tail tip, amnion, 
or liver. Animals were analyzed by skeletal preparations as described previ-
ously (41). WT littermates served as controls. All animal experiments were 
approved by the Landesamt für Gesundheit und Soziales.
Immunohistochemistry, histology, and in situ hybridization. Limbs were 
embedded in paraffin and plastic according to standard procedures. 
Immunohistochemistry was performed on 7-μm paraffin limb sections. 
Further procedures were performed as previously described (27). Rabbit 
anti-Hoxa13 ( #ARP31955_P050; Aviva Systems Biology), rabbit anti-
Hoxd13 (gift from Atsushi Kuroiwa, Division of Biological Sciences, 
Nagoya University, Nagoya, Japan), and rabbit anti–collagen I (ab21286; 
Biozol) were used as primary antibodies. Alexa Fluor 488–conjugated goat 
anti-rabbit (Invitrogen) was used as secondary antibody. Micrographs were 
taken with an AxioVert 200 fluorescence microscope (Zeiss). In situ hybrid-
ization was performed as described previously (42).
chMM culture. chMM cultures were prepared as described previously (43). 
Cells were infected with concentrated viral supernatants containing the cDNA 
encoding WT Hoxd13, Hoxd13+7Ala, Hoxd13+14Ala, Hoxd11, Hoxd12, and 
Hoxa13. Infection with empty RCASBP virus (44) was used as a control. For 
each condition, quadruplicate micromasses were cultivated in parallel. qPCR 
was performed as previously described (45) with gene-specific primers.
Immunofluorescence. Cos-1 (CV-1 origin, SV40) cells were cultured, trans-
fected, and incubated with antibodies as previously described (11).
Western blot. For Western blot, E13.5 limbs of WT and spdh were lysed by 
50 mM HEPES buffer supplemented with protease inhibitors and homog-
enized by shearing with a 1-ml syringe. Membranes were probed with the 
following antibodies: 1:1000 rabbit anti-Hoxa13 (#ARP31955_P050; Aviva 
Systems Biology) and 1:8000 rabbit anti-Hoxd13 (gift from Atsushi Kuroi-
wa). Protein visualization on Western blot membrane was performed by 
chemiluminescence (Roth) after incubation with 1:1000 peroxidase-conju-
gated goat-anti-rabbit (Oncogene) antibody. Specific signals were quanti-
fied using a Western blot imager.
ChIP and luciferase reporter assay. RCASBP virus–infected chMM cultures 
expressing an N-terminal FLAG-tagged Hoxd13 were cultured for 9 and 
12 days. ChIP procedures were performed as previously described (27). 
Primers were as follows: P1 forward, TATATCGCTGTGGATGCCAGG; 
P1 reverse, TTTTGACAAAAGGCCCGTG; P2 forward, GTGTGAAT-
GCTTCATTCGCCT; P2 reverse, ACCGCACTTGTGGTTCTGTG; P3 
forward, GGTTAAGCTCCGCAGGTCAC; P3 reverse, TTACTGACTCT-
GTTGGTCTCAGTGG; P4 forward, CAGCCACTGAGACCAACAGA; P4 
reverse, TGTGAAAAGCGAGGAAACAA. For luciferase reporter assay, 
a murine Runx2 promoter region from –421 bp to +122 bp (based on 
GenBank AF005936) was amplified from genomic mouse DNA with 
specific primers GATCGGTACCGCTATAACCTTCTGAATGCCAG 
(forward) and GATCGGATCCTGCATGGACTGTGGTTA (reverse) and 
cloned into pGL3-basic luciferase reporter vector. Mutation of puta-
tive Hox-binding sites was performed using the following primers: for 
mutation of binding site 1 at position –380, CTTACCACAAGCCTGT-
GGTCAGAGGGAGAAAGG (forward) and CCTTTCTCCCTCTGAC-
CACAGGCTTGTGGTAAG (reverse); for mutation of binding site 2 at 
position –90, CAGTAATAGTGCTTGCACACACTAGGAGTTTTAAAGC 
(forward) and GCTTTAAAACTCCTAGTGTGTGCAAGCACTAT-
TACTG (reverse); for mutation of binding site 3 at position –78, CTT-
GCAAAAAATAGGAGTGTGACAGCTTTTGCTTTTTTGG (forward) 
and CCAAAAAAGCAAAAGCTGTCACACTCCTATTTTTTGCAAG 
(reverse); for mutation of binding site 4 at position –63, GAGTTT-
TAAAGCTTTTGCTGTGTGGGATTGTGTGAATG (forward) and 
CATTCACACAATCCCACACAGCAAAAGCTTTAAAACTC (reverse); 
for mutation of binding site 5 at position +47, TCTGGCGTTTAAAT-
GGTGACTCTCTGCAGGTCACTA (forward) and TAGTGACCTG-
CAGAGAGTCACCATTTAAACGCCAGA (reverse). Deletion of binding 
sites 2–4 was performed by PCR using primers flanking the putative 
binding sites and religation of the PCR product: GGATTGTGTGAAT-
GCTTCATTCG (forward) and CAAGCACTATTACTGGAGAGACAG 
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(reverse). The Runx2 promoter fragment in pGL3-basic was used as 
a template for mutagenesis PCRs. After mutagenesis, promotor frag-
ments were excised by KpnI/NcoI and cloned into pGL3 basic. NIH/3T3 
cells were transfected using PolyFect (QIAGEN) in 24-well plates with 
the reporter constructs (250 ng/well) together with an expression vec-
tor containing either the different Hox constructs or an empty vector 
as control (100 ng/well). pRL-CMV (5 ng/well ) were cotransfected for 
normalization. Cells were lysed with 100 μl passive lysis buffer (Dual 
Luciferase Assay Kit; Promega). 5 μl of the lysate was measured using 
the Dual-Glo Luciferase Assay Kit (Promega) with 25 μl of the assay 
reagents each. Measurements were performed on a 1450 MicroBeta 
Scintillation and Luminescence Counter (PerkinElmer).
Statistics. Graphs show mean ± SD of triplicate samples.
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